Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
China · Delayed Price · Currency is CNY 27.92
-0.74 (-2.58%)
May 8, 2026, 3:04 PM CST
SHE:300204 Market Cap
SHE:300204 has a market cap or net worth of 13.34 billion as of May 8, 2026. Its market cap has increased by 337.62% in one year.
Market Cap
13.34B
Enterprise Value
13.32B
Revenue
203.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.92
Market Cap Chart
Since April 15, 2011, SHE:300204's market cap has increased from 3.33B to 13.34B, an increase of 300.91%. That is a compound annual growth rate of 9.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 13.34B | 2.20% |
| Dec 31, 2025 | 13.05B | 268.69% |
| Dec 31, 2024 | 3.54B | -27.07% |
| Dec 29, 2023 | 4.85B | -24.38% |
| Dec 30, 2022 | 6.42B | -22.12% |
| Dec 31, 2021 | 8.24B | 94.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mabwell (Shanghai) Bioscience | 15.10B |
| Inner Mongolia Furui Medical Science | 14.83B |
| Anhui Anke Biotechnology (Group) | 14.77B |
| Chengdu Olymvax Biopharmaceuticals | 14.22B |
| Chengzhi | 13.68B |
| Tibet Cheezheng Tibetan Medicine | 13.08B |
| InventisBio | 12.80B |
| Hualan Biological Vaccine | 12.61B |